Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Milan criteria.

Liu PH, Lee YH, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI.

Ann Surg Oncol. 2014 Nov;21(12):3835-43. doi: 10.1245/s10434-014-3831-2. Epub 2014 Jun 6.

PMID:
24903236
2.

Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.

Liver Transpl. 2011 May;17(5):556-66. doi: 10.1002/lt.22273.

3.

Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.

Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.

J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077.

PMID:
26259976
4.

Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.

Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Pai JT, Loong CC, Chiou YY, Lee RC, Lee FY, Huo TI, Lee SD.

Ann Surg Oncol. 2012 Mar;19(3):842-9. doi: 10.1245/s10434-011-2060-1. Epub 2011 Sep 13.

PMID:
21913008
5.

Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond Milan criteria independent of performance status.

Liu PH, Lee YH, Hsu CY, Hsia CY, Huang YH, Chiou YY, Lin HC, Huo TI.

J Gastrointest Surg. 2014 Sep;18(9):1623-31. doi: 10.1007/s11605-014-2546-9. Epub 2014 May 29.

PMID:
24871082
6.

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.

Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK.

Korean J Intern Med. 2016 Mar;31(2):242-52. doi: 10.3904/kjim.2015.112. Epub 2016 Feb 15.

7.

Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis.

Liu PH, Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI.

Medicine (Baltimore). 2014 Dec;93(28):e264. doi: 10.1097/MD.0000000000000264. Erratum in: Medicine (Baltimore). 2015 Jan;94(4):1.

8.

Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.

Liu PH, Lee YH, Hsia CY, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI.

Ann Surg Oncol. 2014 Jun;21(6):1825-33. doi: 10.1245/s10434-014-3510-3. Epub 2014 Feb 6.

PMID:
24499831
9.

Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.

Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, Yamamoto H.

Radiology. 2013 Dec;269(3):927-37. doi: 10.1148/radiol.13130387. Epub 2013 Oct 28.

PMID:
24086071
10.

Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.

Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY.

J Gastroenterol Hepatol. 2014 May;29(5):1056-64. doi: 10.1111/jgh.12507.

PMID:
24372785
11.

[Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].

Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.

Korean J Hepatol. 2009 Dec;15(4):474-85. doi: 10.3350/kjhep.2009.15.4.474. Korean.

12.

Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.

Ni JY, Liu SS, Xu LF, Sun HL, Chen YT.

World J Gastroenterol. 2013 Jun 28;19(24):3872-82. doi: 10.3748/wjg.v19.i24.3872.

13.

[Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].

Guo Z, Xiang B, Zhang J, Jiang J, Li L.

Zhonghua Yi Xue Za Zhi. 2014 May 27;94(20):1526-9. Chinese.

PMID:
25146737
14.

Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria.

Zhang L, Yin X, Gan YH, Zhang BH, Zhang JB, Chen Y, Xie XY, Ge NL, Wang YH, Ye SL, Ren ZG.

BMC Gastroenterol. 2014 Jan 10;14:11. doi: 10.1186/1471-230X-14-11.

15.

Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.

Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.

Eur J Radiol. 2012 Mar;81(3):e189-93. doi: 10.1016/j.ejrad.2011.01.122. Epub 2011 Feb 25.

PMID:
21353417
16.

Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria.

Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Lee FY, Huo TI.

Ann Surg Oncol. 2013 Jun;20(6):2035-42. doi: 10.1245/s10434-012-2847-8. Epub 2013 Jan 11.

PMID:
23306955
17.

Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Cao JH, Zhou J, Zhang XL, Ding X, Long QY.

J Huazhong Univ Sci Technolog Med Sci. 2014 Oct;34(5):692-700. doi: 10.1007/s11596-014-1338-5. Epub 2014 Oct 16.

PMID:
25318879
18.

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.

Liu PH, Hsia CY, Lee YH, Hsu CY, Huang YH, Su CW, Lee RC, Lin HC, Huo TI.

J Surg Oncol. 2015 Mar 15;111(4):404-9. doi: 10.1002/jso.23854. Epub 2015 Feb 2.

PMID:
25643842
19.

Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.

Guo Z, Zhong JH, Jiang JH, Zhang J, Xiang BD, Li LQ.

Ann Surg Oncol. 2014 Sep;21(9):3069-76. doi: 10.1245/s10434-014-3704-8. Epub 2014 Apr 12.

PMID:
24728740
20.

Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center.

Bharadwaz A, Bak-Fredslund KP, Villadsen GE, Nielsen JE, Simonsen K, Sandahl TD, Grønbæk H, Nielsen DT.

Acta Radiol. 2016 Jul;57(7):844-51. doi: 10.1177/0284185115603246. Epub 2015 Sep 3.

PMID:
26342009

Supplemental Content

Support Center